Search

Your search keyword '"Bouma, Gerd"' showing total 650 results

Search Constraints

Start Over You searched for: Author "Bouma, Gerd" Remove constraint Author: "Bouma, Gerd" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
650 results on '"Bouma, Gerd"'

Search Results

1. Coeliakie

3. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

7. Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study

9. Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

10. OS-015 Time to complete biochemical response and disease progression in autoimmune hepatitis

11. Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study

13. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

14. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

15. Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease.

17. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

19. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial

20. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

22. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

23. Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice

25. Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis

26. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis

27. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients

28. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis

29. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.

32. Lack of biochemical response after diagnosis is associated with cirrhosis development during follow-up in autoimmune hepatitis

33. Interleukin 12

34. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.

35. Voedselovergevoeligheid

36. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis

39. Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

41. A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis

44. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease

48. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies

50. Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre

Catalog

Books, media, physical & digital resources